Drag a card by its title · ⚙ to size, swap or remove

The company

Helus Pharma Inc.

HELP · Nasdaq

Health CareBiotechnologyLeading

HELP stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 14 weeks. It is 35.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 14 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $19.3M
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 97 (+22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9

Sale orders, 12 months0

Buyers · sellers4 · 0

Who	Did	Shares	Traded
Greg CaversChief Financial Officer	bought	3,000at $12.91	29 Sep 2026filed 1 Oct 2026
Michael HalsteadChief Executive Officer	bought	100,000at $13.47	21 Sep 2026filed 21 Sep 2026
Eric H. L. SoExecutive Chair	bought	100,000at $12.39	8 Sep 2026filed 11 Sep 2026
Paul GlavineChief Growth Officer	bought	100,000at $12.47	8 Sep 2026filed 11 Sep 2026
Paul GlavineChief Growth Officer	bought	100,000at $12.47	8 Sep 2026filed 11 Sep 2026
Eric H. L. SoExecutive Chair	bought	100,000at $12.09	4 Sep 2026filed 10 Sep 2026
Paul GlavineChief Growth Officer	bought	100,000at $11.78	3 Sep 2026filed 10 Sep 2026
Eric H. L. SoExecutive Chair	bought	95,000at $11.81	1 Sep 2026filed 9 Sep 2026
Paul GlavineChief Growth Officer	bought	90,000at $11.59	31 Aug 2026filed 9 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders97+22 on the quarter

New · exited32 · 10

Reported value$196.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Venrock Adviser, LLCunchanged · filed 14 Aug 2026	3,851,654$25.5M	00.0%
ORBIMED ADVISORS LLCreduced · filed 14 Aug 2026	3,271,400$21.6M	-561,443−14.6%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	3,060,000$20.2M	+2,360,000+337.1%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	2,632,156$17.4M	+216,315+9.0%
Rosalind Advisors, Inc.added · filed 14 Aug 2026	1,956,814$12.9M	+425,000+27.7%
SPHERA FUNDS MANAGEMENT LTD.added · filed 14 Aug 2026	1,620,753$10.7M	+633,663+64.2%
ACORN CAPITAL ADVISORS, LLCunchanged · filed 14 Aug 2026	1,540,266$10.2M	00.0%
DCF Advisers, LLCadded · filed 10 Aug 2026	1,434,988$9.5M	+743,000+107.4%
Sio Capital Management, LLCnew · filed 14 Aug 2026	1,300,000$8.6M	+1,300,000
Nan Fung Group Holdings Ltdadded · filed 13 Aug 2026	987,222$6.5M	+527,222+114.6%